StockData

Drugs Made In America Acquisition II Corp. (DMII) stock

DMIINasdaqBlank ChecksFiscal year ends December 31Also trades as DMIIR, DMIIU
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 16, 2026
$10.23−0.01 (-0.15%)

Close on Nov 18, 2026Market cap $140.15MP/E –Yield –

Drugs Made In America Acquisition II total assets

Total assets on the balance sheet at the end of each period.

Drugs Made In America Acquisition II's total assets was $518.72M at Sep 30, 2026. For fiscal 2025 it was $504.96M, up 365643.3% from the year before.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$504.96M+365643.3%
FY2024Dec 31, 2024$138.06K–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$518.72M+3.5%
Q2 FY2026Jun 30, 2026$514.10M+372263.7%
Q1 FY2026Mar 31, 2026$509.73M–
Q4 FY2025Dec 31, 2025$504.96M–
Q3 FY2025Sep 30, 2025$501.01M–
Q4 FY2024Dec 31, 2024$138.06K–

More Drugs Made In America Acquisition II figures

See a number that looks wrong?